These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 30245273)
21. Variation in the flavonolignan composition of fruits from different Silybum marianum chemotypes and suspension cultures derived therefrom. Poppe L; Petersen M Phytochemistry; 2016 Nov; 131():68-75. PubMed ID: 27639292 [TBL] [Abstract][Full Text] [Related]
22. Identification of hepatoprotective flavonolignans from silymarin. Polyak SJ; Morishima C; Lohmann V; Pal S; Lee DY; Liu Y; Graf TN; Oberlies NH Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5995-9. PubMed ID: 20231449 [TBL] [Abstract][Full Text] [Related]
23. The silymarin composition… and why does it matter??? Chambers CS; Holečková V; Petrásková L; Biedermann D; Valentová K; Buchta M; Křen V Food Res Int; 2017 Oct; 100(Pt 3):339-353. PubMed ID: 28964357 [TBL] [Abstract][Full Text] [Related]
27. Determination of Flavonolignan Compositional Ratios in Chen W; Zhao X; Huang Z; Luo S; Zhang X; Sun W; Lan T; He R Molecules; 2024 Jun; 29(13):. PubMed ID: 38998902 [TBL] [Abstract][Full Text] [Related]
29. Absolute configuration of isosilybin A by X-ray crystallography of the heavy atom analogue 7-(4-Bromobenzoyl)isosilybin A. Sy-Cordero AA; Day CS; Oberlies NH J Nat Prod; 2012 Nov; 75(11):1879-81. PubMed ID: 23116206 [TBL] [Abstract][Full Text] [Related]
31. Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes. Faisal Z; Mohos V; Fliszár-Nyúl E; Valentová K; Káňová K; Lemli B; Kunsági-Máté S; Poór M Biomed Pharmacother; 2021 Jun; 138():111459. PubMed ID: 33706132 [TBL] [Abstract][Full Text] [Related]
32. Electrochemical investigation of flavonolignans and study of their interactions with DNA in the presence of Cu(II). Zatloukalová M; Křen V; Gažák R; Kubala M; Trouillas P; Ulrichová J; Vacek J Bioelectrochemistry; 2011 Oct; 82(2):117-24. PubMed ID: 21764394 [TBL] [Abstract][Full Text] [Related]
33. Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners. Křen V Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360650 [TBL] [Abstract][Full Text] [Related]
34. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Davis-Searles PR; Nakanishi Y; Kim NC; Graf TN; Oberlies NH; Wani MC; Wall ME; Agarwal R; Kroll DJ Cancer Res; 2005 May; 65(10):4448-57. PubMed ID: 15899838 [TBL] [Abstract][Full Text] [Related]
35. Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study. Trouillas P; Marsal P; Svobodová A; Vostálová J; Gazák R; Hrbác J; Sedmera P; Kren V; Lazzaroni R; Duroux JL; Walterová D J Phys Chem A; 2008 Feb; 112(5):1054-63. PubMed ID: 18193843 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models. Bijak M; Synowiec E; Sitarek P; Sliwiński T; Saluk-Bijak J Nutrients; 2017 Dec; 9(12):. PubMed ID: 29240674 [TBL] [Abstract][Full Text] [Related]
37. Silybin and 2,3-Dehydrosilybin Flavonolignans as Free Radical Scavengers. Reina M; Martínez A J Phys Chem B; 2015 Sep; 119(35):11597-606. PubMed ID: 26259041 [TBL] [Abstract][Full Text] [Related]
38. Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin. Tvrdý V; Pourová J; Jirkovský E; Křen V; Valentová K; Mladěnka P Med Res Rev; 2021 Jul; 41(4):2195-2246. PubMed ID: 33587317 [TBL] [Abstract][Full Text] [Related]
40. Linear regression analysis of silychristin A, silybin A and silybin B contents in AbouZid SF; Ahmed HS; Abd El Mageed AMA; Moawad AS; Owis AI; Chen SN; Nachtergael A; McAlpine JB; Friesen JB; Pauli GF Nat Prod Res; 2020 Jan; 34(2):305-310. PubMed ID: 30488719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]